In 154 children aged 6-36 months with functional constipation, 4 weeks of the probiotic Lacticaseibacillus rhamnosus MP108 raised treatment success versus maltodextrin placebo (83.1% vs 63.6%, P=0.006), with more frequent, softer stools.
RCTn = 154
Peng et al. Effects of Lacticaseibacillus rhamnosus MP108 on functional constipation symptoms and gut microbiota in children